期刊文献+

416例婴幼儿体外循环心内直视术后死亡病例分析 被引量:4

Mortality analysis of 416 open heart surgery in infant undergoing cardiopulmonary bypass
原文传递
导出
摘要 目的总结416例婴幼儿心内直视术患儿死亡病例的年龄分布特点及死亡原因.方法分析416例婴幼儿先天性心脏病患儿的临床资料,男249例,女167例,平均年龄(13.1±9.3)个月.结果416例婴幼儿体外循环心内直视术后共死亡21例,病死率5.0%;其中2004年1月~12月的144例患儿中死亡4例,病死率2.8%.婴幼儿的病死率在各年龄段的分布中以小于1岁的患儿较高.在死亡原因方面,以死于低心排综合征的婴幼儿比例最高,占21例死亡婴幼儿的57.1%(12/21),其次是死于呼吸功能衰竭的婴幼儿占21例死亡婴幼儿的28.6%(6/21).复杂先天性心脏病死亡病例在各年龄段死亡病例中占有较大比例.结论婴幼儿患儿体外循环心内直视术时年龄越小病死率越高,死于心、肺功能衰竭的患儿比例较高;因此在提高婴幼儿各种先心病矫治技术的同时应加强体外循环心脏手术中的心肺保护效果. Objective To review the possible cause ot mortality in intants undergoing openheart surgery with cardiopulmonary bypass (CPB). Methods Records of 416 infants with congenital heart disease who underwent open heart surgery were analyzed. There were 249 boys and 167 girls with age ranging from one to thirty-six months (average: 13.1 ±9. 3). Results Of 416 cases, thirty- six patients died (5. 0%). In 2004,the infant mortality rate of open heart operation was 2. 8%. Of all cases, the death rate of 1~6 month infants was highest (9. 6%), those of 7~12 months, 13~25 month and 25~36 month being 6. 3% ,5.0% ,3. 1% respectively. The most common cause of rate was low cardiac output (57.1%). Complex congenital heart disease accounted for most of the mortality. Conclusions The death rate increased with the decreasing age. The main cause of death was cardiopulmonary failure.
出处 《中华小儿外科杂志》 CSCD 北大核心 2005年第10期530-532,共3页 Chinese Journal of Pediatric Surgery
基金 国家十五科技攻关计划课题之一<提高重症婴幼儿先心病手术疗效的研究> 编号2004BA7091307
  • 相关文献

参考文献6

二级参考文献21

  • 1[1]Haslam PL,Baker CS,Hughes DA,et al.Pulmonary surfactant composition early in development of acute lung injury after cardiopulmonary bypass:prophylactic use of surfactant therapy[J].Int J Exp Pathol,1997,78(4):277-289.
  • 2[2]LeVine AM, Lotze A, Stanley S,et al. Surfactant content in children with inflammatory lung disease[J].Crit Care Med,1996,24(6):1062-1067.
  • 3[3]Griese M. Pulmonary surfactant in health and human lung diseases: state of the art[J]. Eur Respir J,1999,13(6):1455-1476.
  • 4[4]Chai PJ, Williamson JA, Lodge AJ,et al. Effects of ischemia on pulmonary dysfunction after cardiopulmonary bypass[J]. Ann Thorac Surg,1999,67(3):731-735.
  • 5[5]Millar KJ,Dargaville PA,South M,et al.Pulmonary surfactant and cardiopulmonary bypass in infants[J]. J Thorac Cardiovasc Surg,2000,119(1):192-195.
  • 6[6]McGowan FX,Ikegami M,del Nido PJ,et al.Cardiopulmonary bypass significant reduces surfactant activity in children[J].J Thorac Cardiovasc Surg,1993,106(6):968-977.
  • 7[7]Raymondos K, Leuwer M, Haslam PL,et al. Compositional, structural, and functional alterations in pulmonary surfactant in surgical patients after the early onset of systemic inflammatory response syndrome or sepsis[J].Crit Care Med,1999,27(1):12-13.
  • 8[8]Cane RD, Neymour R. Pulmonary surfactant in acute lung injury[J].Crit Care Med,1999,27(1):82-89.
  • 9[9]Griese M, Wilnhammer C, Jansen S,et al. Cardiopulmonary bypass reduces pulmonary surfactant activity in infants[J].J Thorac Cardiovasc Surg,1999,118(2):237-244.
  • 10[10]Paul DA, Greenspan JS, Davis DA,et al.The role of cardiopulmonary bypass and surfactant in pulmonary decompensation after surgery for congenital heart disease[J].J Thorac Cardiovasc Surg,1999,117(5):1025-1026.

共引文献81

同被引文献22

  • 1吴忠仕,胡建国,尹邦良,杨一峰,周新民,刘锋,罗会昭.体重6kg以下婴儿室间隔缺损的外科治疗[J].中国胸心血管外科临床杂志,2005,12(5):320-322. 被引量:7
  • 2[2]Haneda K.Late results after correction of ventricular septal defect with severe pulmonary hypertension.Tohoku J Exp Med,1994,174:41-48.
  • 3Rossi AF,Seiden HS,Sadeghi AM,et al.The outcome of cardiac operations in infants weighing two kilogrames or less[J].J Thorac Cardiovasc Surg,1998,116:28-35.
  • 4Su ZK,Sun Y,Yang YM,et al.Lung function after deep hypothermic cardiopulmonary bypass in infants[J].2003,11(4):328 -331.
  • 5Huang H,Yao T,Wang W,et al.Continuous ultrafiltration attenuates the pulmonary injury that follows open heart surgery with cardiopulmonary bypass[J].Ann Thorac Surg,2003,76(1):136-140.
  • 6Kreimeier U,Messmer K. Small-volume resuscitation:from experimental evidence to clinical routine.Advantages and disadvantagea of hypertonic solutions[J].Acta Anaesthesiologica Scandinavica,2002.625-638.doi:10.1034/j.1399-6576.2002.460601.x.
  • 7Soski L,Davidovi L,Miliei B. Effect of hypertonic-hyperoncotic solution infusion on tissue perfusion during surgical treatment of the abdominal aorta[J].Vojnosanitetski Pregled,2007,(10):685-689.doi:10.2298/VSP0710685S.
  • 8Carli P,Orliaguet G. Severe traumatic brain injury in children[J].The Lancet,2004.584-585.doi:10.1016/S0140-6736(04)15626-2.
  • 9Rocha ESR,Caneo LF,Loureneo FDD. First use of hypertonic saline dextran in ehildren:a study in safety and effectiveness for atrial septal defect surgery[J].Shock,2003,(5):427-430.doi:10.1097/01.SHK.0000094037.09886.d2.
  • 10Ryukoh OMD,Kouichiro SMD,Masahiko KMD. Effects of hypertonic saline and dextran 70.on cardiac contractility after hemorrhagic shock[J].Journal of Trauma-Injury Infection and Critical Care,1998,(01):59-69.doi:10.1097/00005373-199801000-00005.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部